Literature DB >> 26432481

Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions.

Hans Lassmann1, Jack van Horssen2.   

Abstract

Entities:  

Keywords:  Astrocytes; Microglia; Multiple sclerosis; Neurons; Oligodendrocytes; Oxidative stress

Mesh：

Substances：

Year:  2015        PMID： 26432481     DOI： 10.1016/j.bbadis.2015.09.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  51 in total

1.  Effect of High-Intensity Exercise on Multiple Sclerosis Function and Phosphorous Magnetic Resonance Spectroscopy Outcomes.

Authors:  Anna Orban; Bharti Garg; Manoj K Sammi; Dennis N Bourdette; William D Rooney; Kerry Kuehl; Rebecca I Spain
Journal:  Med Sci Sports Exerc       Date:  2019-07       Impact factor: 5.411

2.  Upregulating Nrf2 in the RVLM ameliorates sympatho-excitation in mice with chronic heart failure.

Authors:  Anyun Ma; Juan Hong; Julia Shanks; Tara Rudebush; Li Yu; Bryan T Hackfort; Hanjun Wang; Irving H Zucker; Lie Gao
Journal:  Free Radic Biol Med       Date:  2019-06-07       Impact factor: 7.376

Review 3.  Beyond the neuron: Role of non-neuronal cells in stress disorders.

Authors:  Flurin Cathomas; Leanne M Holt; Eric M Parise; Jia Liu; James W Murrough; Patrizia Casaccia; Eric J Nestler; Scott J Russo
Journal:  Neuron       Date:  2022-02-18       Impact factor: 17.173

4.  White matter microstructure differences in individuals with dependence on cocaine, methamphetamine, and nicotine: Findings from the ENIGMA-Addiction working group.

Authors:  Jonatan Ottino-González; Anne Uhlmann; Sage Hahn; Zhipeng Cao; Renata B Cupertino; Nathan Schwab; Nicholas Allgaier; Nelly Alia-Klein; Hamed Ekhtiari; Jean-Paul Fouche; Rita Z Goldstein; Chiang-Shan R Li; Christine Lochner; Edythe D London; Maartje Luijten; Sadegh Masjoodi; Reza Momenan; Mohammad Ali Oghabian; Annerine Roos; Dan J Stein; Elliot A Stein; Dick J Veltman; Antonio Verdejo-García; Sheng Zhang; Min Zhao; Na Zhong; Neda Jahanshad; Paul M Thompson; Patricia Conrod; Scott Mackey; Hugh Garavan
Journal:  Drug Alcohol Depend       Date:  2021-11-25       Impact factor: 4.492

Review 5.  Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis.

Authors:  Heather Y F Yong; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2021-11-03       Impact factor: 42.937

6.  Critical Role of Astrocyte NAD+ Glycohydrolase in Myelin Injury and Regeneration.

Authors:  Monica R Langley; Chan-Il Choi; Thais R Peclat; Yong Guo; Whitney L Simon; Hyesook Yoon; Laurel Kleppe; Claudia F Lucchinetti; Claudia C S Chini; Eduardo N Chini; Isobel A Scarisbrick
Journal:  J Neurosci       Date:  2021-09-07       Impact factor: 6.167

7.  Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury.

Authors:  Lesley A Ward; Dennis Sw Lee; Anshu Sharma; Angela Wang; Ikbel Naouar; Xianjie I Ma; Natalia Pikor; Barbara Nuesslein-Hildesheim; Valeria Ramaglia; Jennifer L Gommerman
Journal:  JCI Insight       Date:  2020-01-16

8.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

Review 9.  New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis.

Authors:  D Michaličková; M Šíma; O Slanař
Journal:  Physiol Res       Date:  2019-12-19       Impact factor: 1.881

Review 10.  Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity.

Authors:  Susan J van Rensburg; Ronald van Toorn; Rajiv T Erasmus; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Merlisa C Kemp; Penelope Engel-Hills; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2021-04-28       Impact factor: 3.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.